Stavudine Loaded Microcapsules using various Cellulose Polymers: Preparation and In-Vitro Evaluation
DOI:
https://doi.org/10.37285/ijpsn.2009.2.2.9Abstract
The objective of the present study was to prepare and characterize the microcapsules for the controlled release of Stavudine using cellulose acetate butyrate (CAB), ethyl cellulose (EC), hydroxy propyl methyl cellulose phthalate (HPMCP). The microcapsules were prepared by solvent evaporation method using acetone and liquid paraffin as a drug dispersion and liquid manufacturing phase, respectively. The prepared microcapsules were characterized for particle size distribution (PSD), percent drug content, entrapment efficiency, Fourier Transform Infrared Spectroscopy (FTIR), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and in vitro dissolution studies. The prepared microcapsules were filled in hard gelatin capsules and kept for accelerated stability study as per ICH guidelines for about 3 months. The prepared microcapsules were spherical and free flowing. The entrapment efficiency was found to be 25-45%. The release of drug from the microcapsules was extended upto 12 hours and more. FTIR and DSC thermo graphs showed stable character of stavudine. Scanning electron microscopic study revealed that then microcapsules were spherical and porous in nature. The release kinetics study revealed that the prepared microcapsules were best fitted to the Higuchi model, first order and followed by Zero order and indicating that the drug release was diffusion controlled. The release was mainly influenced by the type of polymer and its viscosity. The DSC study revealed that there is no drug to polymer interaction and showed the stable character of the drug which was further confirmed by the assay of accelerated stability of microcapsules.
Downloads
Metrics
Keywords:
Stavudine, Cellulose polymers, Microcapsules, Controlled release, StabilityDownloads
Published
How to Cite
Issue
Section
References
C Katlama, M AValantin, S Matheron, A Coutellier. Efficacy and tolerability of stavudine plus stavudine in treatment-naive and treatment experienced patients with HIV-1 infection. Ann Intern Med.129:525-531(1998).
C Sanchez-Lafuente , S Furlanetto, Didanosine extended release matrix tablets: optimization of formulation variables using statistical experimental design. Int J Pharm. 237:107-118 (2002).
D P Merrill, M Moonis, T C Chou M S Hirsch. Stavudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J Infect Dis. 173:355-364(1996).
D.R Bhumkar, M Maheshwari, V.B Patil Studies on effect of variables by response surface methodology for naproxen microspheres. Indian Drugs. 40: 455-461(2003).
F Becher, R Landman, S Mboup, C Ndeye Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients. AIDS. 18:181-187(2004).
G Amitava, N Udaya Kumar, R Partha, Development, evaluation and method selection for the preparation of lamivudine microspheres, The Int J Pharmacy, Pharmacy on-line, www.priory.com,( 2007).
H P Katy, Jo E. Barrett, S Shuching, The pharmacokinetics of stavudine hosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS., 1999,13:2239-2250.
Indian Pharmacopoeia. 5th edition. Controller of Publication.328-329,393-395(1996).
K Prakash, P N Raju, K K Shanta, M N Lakshmi. Preparation and characterization of lamivudine microcapsules using various cellulose polymers. Tropical Journal of Pharmaceutical Research. 6: 841-847(2007).
M.C Gohel, R.K Parik, A.F Amin. Preparation and formulation optimization of sugar crosslinking gelatin microspheres of diclofenac sodium. Indian J Pharm Sci. 67: 575-581 (2005).
P A Furman, J A Fyfe, St M H Clair, C A Richards, Phosphorylation of 3′-azido-3′-eoxythymidine and selective interaction of the 5′-triphosphatewith human immunodeficiency virus reverse ranscriptase. Proc Natl Acad Sci. USA.83:8333-8337(1986).
S Goodman, A Gilman. The Pharmacological Basis of Therapeutics, Macmillan Publishing Company, New York, 1985.
S Himadri, J S Kumar, inventors. Long acting composition containing zidovudine and Stavudine. US patent publication US 20050175694A1. (2005).
S Jain, R B Umamaheshwari, D Bhadra, N K Jain. Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharm Sci. 66:72-81(2004).
S K Sahoo, A A Mallick, B B Barik Formulation and in vitro evaluation of eudragit microspheres of stavudine. Tropical Journal of Pharmaceutical Research. 4: 369-375 (2005).
Y W Chien, L L Wearley. AIDS and chemotherapy. Drugs Today.25:19-25(1989).